| Population pharmacokinetic-pharmacodynamic modeling of ropivacaine in spinal anesthesia Z Djerada, C Feliu, Y Cazaubon, F Smati, P Gomis, D Guerrot, B Charbit, ... Clinical pharmacokinetics 57, 1135-1147, 2018 | 36 | 2018 |
| Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen Y Cazaubon, N Venisse, O Mimoz, P Maire, M Ducher, L Bourguignon, ... Journal of Antimicrobial Chemotherapy 72 (10), 2804-2812, 2017 | 33 | 2017 |
| Pharmacokinetics of vancomycin in elderly patients aged over 80 years L Bourguignon, Y Cazaubon, G Debeurme, C Loue, M Ducher, S Goutelle Antimicrobial agents and chemotherapy 60 (8), 4563-4567, 2016 | 25 | 2016 |
| Complementary role of P2 and adenosine receptors in ATP induced-anti-apoptotic effects against hypoxic injury of HUVECs C Feliu, H Peyret, G Poitevin, Y Cazaubon, F Oszust, P Nguyen, H Millart, ... International journal of molecular sciences 20 (6), 1446, 2019 | 22 | 2019 |
| Polymorphisms in Slco1B3 and Nr1I2 as Genetic Determinants of Hematotoxicity of Carboplatin and Paclitaxel Combination LC Mbatchi, A Schmitt, F Thomas, Y Cazaubon, J Robert, S Lumbroso, ... Pharmacogenomics 16 (13), 1439-1450, 2015 | 21 | 2015 |
| Quantification of 15 antibiotics widely used in the critical care unit with a LC-MS/MS system: an easy method to perform a daily therapeutic drug monitoring C Feliu, C Konecki, T Candau, D Vautier, C Haudecoeur, C Gozalo, ... Pharmaceuticals 14 (12), 1214, 2021 | 20 | 2021 |
| Population pharmacokinetics of articaine with 1: 200,000 epinephrine during third molar surgery and simulation of high-dose regimens Y Cazaubon, C Mauprivez, C Feliu, L Binet, O Oget, C Gozalo, Z Djerada European Journal of Pharmaceutical Sciences 114, 38-45, 2018 | 19 | 2018 |
| Population pharmacokinetics of isavuconazole in critical care patients with COVID-19-associated pulmonary aspergillosis and Monte Carlo simulations of high off-label doses L Perez, P Corne, G Pasquier, C Konecki, M Sadek, C Le Bihan, ... Journal of Fungi 9 (2), 211, 2023 | 17 | 2023 |
| Population pharmacokinetics modelling and simulation of mitotane in patients with adrenocortical carcinoma: an individualized dose regimen to target all patients at three months? Y Cazaubon, Y Talineau, C Feliu, C Konecki, J Russello, O Mathieu, ... Pharmaceutics 11 (11), 566, 2019 | 17 | 2019 |
| External evaluation of population pharmacokinetic models and Bayes-based dosing of infliximab C Konecki, C Feliu, Y Cazaubon, D Giusti, M Tonye-Libyh, H Brixi, ... Pharmaceutics 13 (8), 1191, 2021 | 16 | 2021 |
| Quantification of methadone, buprenorphine, naloxone, opioids, and their derivates in whole blood by liquid chromatography-high-resolution mass spectrometry: Analysis of their … C Feliu, C Konecki, L Binet, D Vautier, C Haudecoeur, O Oget, A Fouley, ... Journal of Chromatography B 1152, 122226, 2020 | 15 | 2020 |
| Real life population pharmacokinetics modelling of eight factors VIII in patients with severe haemophilia A: is it always relevant to switch to an extended half-life? Q Allard, Z Djerada, C Pouplard, Y Repessé, D Desprez, H Galinat, ... Pharmaceutics 12 (4), 380, 2020 | 13 | 2020 |
| Therapeutic drug monitoring of mitotane: Analytical assay and patient follow‐up C Feliu, Y Cazaubon, H Guillemin, D Vautier, O Oget, H Millart, C Gozalo, ... Biomedical Chromatography 31 (11), e3993, 2017 | 10 | 2017 |
| Are ciprofloxacin dosage regimens adequate for antimicrobial efficacy and prevention of resistance? Pseudomonas aeruginosa bloodstream infection in elderly … Y Cazaubon, L Bourguignon, S Goutelle, O Martin, P Maire, M Ducher Fundamental & Clinical Pharmacology 29 (6), 615-624, 2015 | 10 | 2015 |
| Drowsiness and uncommon fever in a child after cannabis ingestion C Feliu, Y Cazaubon, A Fouley, H Guillemin, H Millart, C Gozalo, ... Annales de Biologie Clinique 75 (4), 462-465, 2017 | 9 | 2017 |
| About 5 cases with 3 Meo-PCP including 2 deaths and 3 non-fatal cases seen in France in 2018 F Grossenbacher, Y Cazaubon, C Feliu, A Ameline, P Kintz, O Passouant, ... Toxicologie Analytique Et Clinique 31 (4), 332-336, 2019 | 7 | 2019 |
| Comparative evaluation of four commercially available immunoassays for therapeutic drug monitoring of infliximab and adalimumab F Rissel, Y Cazaubon, S Saffar, R Altwegg, M Artasone, C Lozano, ... International Journal of Molecular Sciences 24 (12), 10379, 2023 | 3 | 2023 |
| Development and validation of a non-targeted screening method for most psychoactive, analgesic, anaesthetic, anti-diabetic, anti-coagulant and anti-hypertensive drugs in human … C Feliu, C Konecki, Y Cazaubon, L Binet, D Vautier, A Fouley, C Gozalo, ... Pharmaceuticals 16 (1), 76, 2023 | 3 | 2023 |
| Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock F Grossenbacher, GG Orsini, Y Cazaubon, P Fouret, Z Djerada, ... Therapies 76 (1), 51-53, 2021 | 3 | 2021 |
| Évaluation par méthode in silico du risque d’émergence de la résistance bactérienne des antibiotiques: exemple des fluoroquinolones et des glycopeptides en gériatrie Y Cazaubon Université de Lyon, 2018 | 3 | 2018 |
